Breast cancer screening decision help for women 40–74
Part of Cancer, Skin clinical trials.
This trial tests a breast cancer screening risk and decision aid to help you and your clinician choose the right next steps for screening and referrals. You may benefit by getting clearer, personalized guidance based on your risk.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman age 40 to 74
- You are enrolled in MyChart (online patient portal)
- You can read English
- You do not have a personal history of breast cancer
- You are not currently pregnant and not on hospice care
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a decision aid that helps women aged 39-49 decide about mammograms. It aims to support informed choices in rural areas.
This study tests a decision aid to help women at high risk for breast cancer decide whether to get a screening MRI. It is designed for Black and Latina women who have had a normal mammogram in the past year.
This study tests a decision aid to help women 70 and older with early stage breast cancer choose their treatment. It looks at whether the tool helps patients and their doctors make a confident treatment choice.
This study tests a patient “decision aid” to help people decide about lung cancer screening. It may help you understand risks and benefits and feel more confident about next steps.
This study compares two different ways of teaching women about breast cancer and mammograms. It aims to see which method helps women feel more confident and more likely to get screened.
This study aims to improve breast cancer screening for Black women by providing support and education. If you are a Black woman aged 40 or older and are due for a mammogram, you may be eligible to participate.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.